Back to search

Article

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives

2020-06-08

Abstract excerpt

Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has caused a pandemic of historic proportions and continues to spread globally, with enormous consequences to human health. Currently there is no vaccine, effective therapeutic or prophylactic. Like other betacoronaviruses, attachment and entry of SARS-CoV-2 is mediated by the spike glycoprotein (SGP). In addition to its well-documented interacti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cc8b4ae3-c447-50bf-9187-f32818d6ba4f
DOI
10.1101/2020.06.08.140236
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin DerivativesDOI 10.1101/2020.06.08.140236
Select a neighboring publication to make it the new centre.